Russian Journal of Skin and Venereal Diseases

Peer-review bimonthly medical journal.

Editor-in-chief

Journal founders

  • Izdatelstvo "Meditsyna"
  • Eco-Vector Publishing Group

Publisher

About

The journal covers issues in dermatology, venereology, and dermato-oncology, publishing different typologies of contributions. Among the topics are skin infections of pyococcal origin, mycoses, dermatozoonoses, bullous dermatoses, and cosmetic dermatology.

The journal reviews new textbooks and manuals on dermatology and venereology, discusses new tests and emerging clinical problems, etc. The journal is aimed at practitioners specializing in dermatology, venereology, cosmetology, urology, gynecology, pediatrics and other branches of medicine.

Types of accepted articles

  • reviews
  • systematic reviews and metaanalyses
  • original research
  • clinical case reports and series
  • letters to the editor
  • short communications
  • clinial practice guidelines

 

Publications

  • in English and Russian
  • bimonthly, 6 issues per year
  • continuously in Online First
  • with NO Article Processing Charges (APC)
  • distribution in hybrid mode - by subscription and/or Open Access
    (OA articles with the Creative Commons Attribution 4.0 International License (CC BY-NC-ND 4.0))

Indexation

  • Russian Science Citation Index (Web of Sciences)
  • Russian Science Electronic Library (eLibrary.ru)
  • Google Scholar
  • Ulrich's Periodicals directory
  • WorldCat
  • Crossref

Announcements

 
No announcements have been published.
 
More Announcements...

Current Issue

Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 25, No 1 (2022)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

DERMATO-ONCOLOGY

MicroRNA as a diagnostic marker in cutaneous T-cell lymphomas
Olisova O.Y., Demkin V.V., Chernova N.G., Amshinskaya J.R., Kazakov A.A.
Abstract

BACKGROUND: In recent years, thanks to the development of methods of molecular genetic analysis, microRNA has become one of the promising markers for the diagnosis of many human diseases.

AIMS: to study microRNA as a new method for the diagnosis of fungal mycosis.

MATERIALS AND METHODS: The study included 30 patients with histologically confirmed diagnosis of T-cell lymphomas of the skin, 25 were diagnosed with fungal mycosis, 5 ― Cesari syndrome. The control group consisted of 10 patients with benign lymphoproliferative dermatoses. The patients underwent the determination of microRNA 223, 16, 326, 663, 423, 711 in blood plasma. MicroRNA was also detected in plasma in patients with T-cell lymphomas of the skin at early and late stages.

RESULTS: Statistically significant difference of 223, 16, 326, 711 microRNAs in blood plasma was revealed in patients with fungal mycosis, compared with patients with benign lymphoproliferative dermatoses. Statistically significant difference of 663 microRNA in blood plasma was revealed in patients with T-cell lymphomas of the skin at early and late stages. A statistically significant difference of 223, 711 microRNAs in blood plasma was revealed in patients with fungal mycosis at an early stage compared with patients with benign lymphoproliferative dermatoses.

CONCLUSION: The determination of microRNA 223, 16, 326, 711 in blood plasma can be used for early diagnosis of T-cell lymphomas of the skin.

Russian Journal of Skin and Venereal Diseases. 2022;25(1):5-16
pages 5-16 views

DERMATOLOGY

Clinical and pathogenetic justification of the use of methotrexate in the treatment of progressive non-segmental vitiligo
Tavitova A.R., Lomonosov K.M.
Abstract

BACKGROUND: Vitiligo is an urgent problem both for patients and for the scientific community of dermatologists. There are many studies aimed at finding new methods of therapy for this disease, but there are no effective schemes for repigmentation of foci and stabilization of the process in modern dermatology. In this regard, the search for means that have a pathogenetic effect is relevant.

AIMS: Clinical and laboratory evaluation of the effectiveness of methotrexate in vitiligo.

MATERIALS AND METHODS: Preliminary results of a study of the effectiveness of methotrexate in the treatment of vitiligo are presented. Clinical effects were assessed using the VES index (Vitiligo extent score). The dynamics of immunological parameters and the influence of vitiligo on the quality of life were also determined.

The study included 77 patients suffering from non-segmental vitiligo. All the subjects were divided into 2 groups. Patients of group 1 (39 patients) received methotrexate in combination with phototherapy, patients of group 2 (38 patients) underwent a course of UVB-311nm. The area of depigmentation was determined, and after treatment – repigmentation, relative to the surface area of the body. The dynamics of the immune status against the background of therapy was analyzed. The correlation of the prevalence of the process with the quality of life was evaluated. The duration of the study was 4 months.

RESULTS: There were no statistically significant differences in clinical and laboratory parameters among the groups before treatment. Patients included in group 1 and receiving combination therapy with methotrexate and medium-wave narrow-band therapy with UVB-311nm demonstrated more active repigmentation of vitiligo foci than the studied 2 groups. Also, patients of this group demonstrated the most active positive dynamics of the dermatological quality of life index, correlating with the prevalence of the process. Analysis of the dynamics of immune status indicators allowed us to conclude that the best tendency to normalize cytokine levels among group 1 patients.

CONCLUSIONS: Our study demonstrated the clinical and pathogenetic efficacy of methotrexate. Small doses of the drug are well tolerated, which allows a long-term effect on pathogenetic mechanisms, stabilizing the skin process.

Russian Journal of Skin and Venereal Diseases. 2022;25(1):17-27
pages 17-27 views
Phototherapy for psoriasis
Yazkova O.S., Anpilogova E.M.
Abstract

Psoriasis is a chronic genetically determined disease of a multifactorial nature associated with immune-mediated inflammation and characterized by a recurrent course with frequent associative damage to other organs and systems.

According to global recommendations, nowadays, despite the era of biologic therapy, phototherapy (PUVA and UVB) continues to occupy its important niche in the treatment of moderate-to-severe psoriasis, due to the pathogenetically justified therapeutic effect, safety and low cost of procedures.

The review provides detailed data on the mechanism of action, the effectiveness of phototherapy; as well as potential biomarkers of psoriasis (calprotectin, lipocalin 2, resistin), which can enhance an accuracy assessment of the effectiveness of the treatment and, if necessary, its timely correction, which will allow faster achievement of the desired effect resulting in improvement of the quality of patients’ lives.

Russian Journal of Skin and Venereal Diseases. 2022;25(1):29-39
pages 29-39 views
Combination of actinic, hypertrophic and typical forms of lichen planus in one patient
Shchava S.N., Ivanova I.N., Serdyukova E.A.
Abstract

Lichen planus is a chronically occurring dermatosis of a multifactorial nature, which is characterized by the appearance of flat polygonal itchy papules on the skin and mucous membranes. Dermatosis is often associated with diabetes mellitus and diseases of the gastrointestinal tract, extremely rarely with oncological diseases. Antimalarial drugs with photoprotective, anti-inflammatory, weak immunosuppressive effect are recommended for treatment.

Actinic and hypertrophic forms of lichen planus are atypical forms of the disease. Actinic or tropical lichen planus is rare in the Russian Federation, mainly in the countries of the Middle and Near East, Central Asia, Africa. The actinic form of lichen planus is characterized by localization in open areas of the skin (face, neck). The hypertrophic form of lichen planus is characterized by large papules with a bumpy surface that do not look like a typical form. The rare occurrence of dermatosis and unusual localization leads to difficulty in making a diagnosis.

The article presents a clinical case of a combination of actinic, hypertrophic and typical forms of lichen planus in a patient born in the Caucasus, but having lived in Russia for a long time. The skin process in the patient was widespread, was localized throughout the skin, including the face, neck, mucous membranes of the oral cavity; only the skin of the palms and soles remained free from rashes. The rash was represented by flat polygonal papules, bluish-pink in color, the size of a lentil, and a whitish Wickham mesh on the surface.

Localization in open areas of the skin, combination with hypertrophic papules, outdoor work, severe itching with excoriations led to an incorrect diagnosis, and the ongoing therapy had no effect. To clarify the diagnosis, a histological examination was carried out, which revealed pronounced hyperkeratosis, uneven granulosis, massive papillomatosis, in the papillary and sub-papillary layers of the dermis (stripe-shaped moderate infiltrate of lymphoid elements, histiocytes, minor edema, vasodilation). Adequately selected drug therapy (dexamethasone intramuscularly; chloropyramine intramuscularly; antimalarial agent; nicotinic acid; external ointment dermatol), as well as acupuncture sessions with the second inhibitory method of therapy, led to an improvement in the patient’s condition.

Upon completion of treatment, the patient is recommended photoprotective external agents on exposed skin and a repeated course of acupuncture.

Russian Journal of Skin and Venereal Diseases. 2022;25(1):41-47
pages 41-47 views
Folliculitis decalvans: clinical and morphological characteristics (literature review)
Smirnova I.O., Medetskaya O.M., Bessalova A.Y., Shin N.V.
Abstract

Folliculitis decalvans is a rare disease of primary cicatricial alopecias, about 11% of all alopecias of this group. Dermatosis was first described by the French dermatologist Charles-Eugène Quinquaud in 1888 and 1889. In recent decades, the number of publications devoted to the etiopathogenesis, clinical and histological characteristics, as well as approaches to the treatment of folliculitis decalvans has increased.

The article presents the results of data analysis on the databases Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health, CyberLeninka, RSCI.

The etiopathogenesis of the disease is still unknown. The role of seborrhea and skin colonization by Staphylococcus aureus, as well as impaired local immune response and the presence of a genetic predisposition, have previously been discussed. Folliculitis decalvans is now thought to be a result of persistent disruption of the skin barrier that predisposes to subepidermal invasion by opportunistic microorganisms, including Staphylococcus aureus. Clinical, dermatoscopic (trichoscopic) and histological characteristics of dermatosis are being specified. Its characteristic clinical features are a persistent progressive course, the formation of alopecia foci with a rich red edge, pustules and crusts along the periphery of the alopecia foci, polytrichia and the formation of a dense scar that rises above the surrounding skin. Dermatoscopic characteristics depend on the intensity of the inflammatory process. Specific trichoscopic signs of the disease include follicular pustules, yellow tubular desquamation, yellow crusts, perifollicular erythema, perifollicular hemorrhages, and fine tortuous vessels. Depending on the number of these signs, the degree of inflammation is determined. Histological features of the disease include a massive perifollicular infiltrate, the formation of gaps between the epithelium of the follicles and the surrounding stroma, and in the final stages of the process ― fibrous tracts, diffuse fibrosis in the dermis.

The treatment of folliculitis decalvans are antibacterial drugs, it is also possible to treat with courses of topical corticosteroids, antiseptic solutions.

We assume that the systematization of information about the etiopathogenesis and approaches to the diagnosis and treatment of folliculitis decalvans will improve the diagnosis among other primary cicatricial alopecia and the choice of the tactics of treating folliculitis decalvans.

Russian Journal of Skin and Venereal Diseases. 2022;25(1):49-59
pages 49-59 views
Pyoderma gangrenosum: examination and treatment experience
Teplyuk N.P., Grabovskaya O.V., Kusraeva D.T., Varshavsky V.A.
Abstract

BACKGROUND: Pyoderma gangrenosum is a rare inflammatory skin disease that currently belongs to the group of neutrophilic dermatoses.

AIMS: Development of epidemiological, clinical, laboratory characteristics of patients with pyoderma gangrenosum, as well as the treatment of this disease.

MATERIALS AND METHODS: The study revealed 30 patients, 16 (53%) were women, the average age at the time of diagnosis was 59±16.3 years. The most common localization of rashes was the lower leg 20 patients (67%), lesions of the skin of the face, genitals, and breast rarely noted, in one case, respectively. In 14 patients (47%), two or more ulcers were detected at the same time (max. 9 ulcers). The pathergy phenomenon was positive in 23 patients (77%) of 30. Ulcerative pyoderma gangrenosum occurred in 25 (83%), and extracutaneous pyoderma gangrenosum with lung involvement was identified in one patient. The most common associated disease was rheumatoid arthritis in 6 patients (20%), there were also rare associated diseases, such as hepatitis C two cases, multiple endocrine neoplasia syndrome type 1, autoimmune hepatitis, non-Hodgkin’s lymphoma by one observation. Histological examination revealed neutrophilic infiltration of the dermis in 30 patients (100%), and the presence of leukocytoclastic vasculitis in 16 (53%). Complete scarring during the treatment was observed in 22 patients (73%). Relapses during the observation period were observed in 12 patients (40%), the number of deaths was two cases.

CONCLUSIONS: One of the largest case series of pyoderma gangrenosum to date is presented. During the examination of patients, it was found that neutrophilic infiltration of the dermis is a characteristic sign of the disease. Rare comorbidities (multiple endocrine neoplasia syndrome type 1, autoimmune hepatitis, hepatitis C, non-Hodgkin’s lymphoma) have been found. A sufficiently large percentage of relapses indicates the need for further research to develop an additional examination method for the purpose of modern diagnostics and justification for the timely prescription of targeted therapy.

Russian Journal of Skin and Venereal Diseases. 2022;25(1):61-72
pages 61-72 views
The effectiveness of the IL-17A inhibitor in generalized pustular psoriasis: a clinical case
Olisova O.Y., Snarskaya E.S., Kochergin N.G., Teplyuk N.P., Ignatyev D.V., Tavitova A.R., Makhmudi W.
Abstract

The first clinical case of the effective use of a domestic biological drug inhibitor netakimab ― IL-17A ― in a patient with persistently progressive, torpid to therapy generalized pustular psoriasis Tsumbush is presented. This rare systemic dermatosis refers to severe forms of psoriasis that threaten the patient’s life and require intensive therapy from the very first hours of the manifestation of the disease. The development of pustular psoriasis can be promoted by: long-term therapy with systemic glucocorticosteroids, cytostatics, oral contraceptives, as well as prolonged use of irritating external agents. In some cases, the disease is associated with high emotional stress, stress. In severe generalized pustular psoriasis, biological drugs, cyclosporine, methotrexate, and acitretin are effective.

The article presents summary data on the effectiveness of first- and second-line drugs in the treatment of pustular psoriasis. According to the literature, patients with severe pustular psoriasis, torpid to standard therapy, demonstrate a positive response to treatment with biological drugs in most cases. Anti-TNF-α are the most available biological drugs for the treatment of pustular psoriasis, and anti-IL-12/23 and anti-IL-17A can be considered as the first or second line of therapy for moderate-severe and refractory pustular psoriasis.

The choice of effective therapy for the treatment of pustular psoriasis is an urgent problem of modern dermatology and the presented clinical case demonstrates the effectiveness and pronounced positive therapeutic effect of the IL-17A inhibitor for 1 day in the treatment of generalized pustular psoriasis resistant to previously conducted therapy, which allows us to count on the prospect of further successful use of this targeted drug in the treatment of severe pustular psoriasis.

 

 

 

 

 

Russian Journal of Skin and Venereal Diseases. 2022;25(1):73-83
pages 73-83 views

CHRONICLES

Chronicles of A.I. Pospelov Moscow Dermatovenerology and Cosmetology Society (MSDC was founded on October 4, 1891) Bulletin of the MSDC № 1146
Yakovlev A.B., Maximov I.S.
Abstract

On February 15, 2022, the 1146th meeting of the Moscow Society of Dermatovenereologists and Cosmetologists named after A.I. Pospelov took place.

The meeting was held in a “remote” format. There were 120 participants in total. Accepted as a member of MSDC 1 person.

Three clinical clinical observations are presented. The first of them is a case of giant-cell variant of annular granuloma with extensive skin lesions. Annular granuloma is a benign dermatosis of unclear etiology, prone to spontaneous resolution; it occurs as a reaction to ultraviolet radiation against the background of lymphoproliferative or autoimmune diseases, sarcoidosis, chronic lung diseases, prostate cancer. In the presented case, the clinical diagnosis was confirmed by histological examination.

The second presentation was devoted to livedoid vasculopathy with a tendency to thrombotic complications. This is a relatively rare disease that is excluded from the group of vasculitis due to one distinctive feature ― a pronounced tendency to thrombosis in the absence of indications of the primary nature of inflammation. In therapy, in addition to medications, the appointment of vitamins is mandatory.

The third observation concerned Merkel’s carcinoma, one of the relatively rare but extremely aggressive most malignant forms of skin cancer. With epithelial and neuroendocrine differentiation, which is superior to melanoma in terms of aggressiveness of the course and tendency to metastasis. Due to the rare occurrence of the tumor, diagnostic errors are frequent. Diagnosis requires histological and immunohistochemical examination. Any “inflamed atheroma” or synovial cyst that recurs after surgical treatment should be alarming.

Scientific reports were heard on the biological therapy of psoriasis, a chronic systemic immunoassociated disease of a multifactorial nature with a hereditary predisposition characterized by the formation of inflammatory papules and plaques, often with joint damage (arthropathy), accelerated proliferation of epidermocytes and a violation of their differentiation, an imbalance between pro-inflammatory and anti-inflammatory cytokines and chemokines. And the second scientific report contained information about modern approaches to the treatment of acantholytic pemphigus.

 

Russian Journal of Skin and Venereal Diseases. 2022;25(1):85-91
pages 85-91 views

PHOTO GALLERY

Photogallery. Anogenital (venereal) warts
Dubensky V.V., Dubensky V.V.
Abstract

Anogenital warts are caused by the human papillomavirus (most commonly types 6 and 11, giant condylomas ― types 16 and 18) and are exophytic and endophytic growths on the skin and mucous membranes of the genital and perianal areas. There is no generally accepted classification, but based on clinical manifestations, there are: acute condylomas, papular, patchy, hyperkeratotic, and giant condyloma acuminatum (Buschke–Lowenstein tumor). Anogenital warts can be the result of infection through sexual contact, which is indicated by the synonym “venereal warts”. Anogenital warts is a separate nosology (International Classification of Diseases of the Tenth Revision: A63.0), but can also be part of the symptom complex of immunodeficiency conditions (in particular acquired immunodeficiency syndrome) and neoplasias (squamous cell carcinoma and erythroplasia of Queyrat).

We offer the publication of a photogallery on this problem.

Russian Journal of Skin and Venereal Diseases. 2022;25(1):93-96
pages 93-96 views


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies